CHF 5074 is being studied for its potential therapeutic applications in neurodegenerative diseases, particularly Alzheimer's disease. It has shown promise in reducing amyloid-beta plaque formation, which is a hallmark of Alzheimer's pathology. Additionally, it exhibits anti-inflammatory properties, which may help in mitigating neuroinflammation associated with cognitive decline. Research is ongoing to explore its efficacy and safety as a treatment option for Alzheimer's and other related conditions.